AGM/EGMJun 12, 2026, 04:17 PM
OptimizeRx Shareholders Approve 1M Share Increase for Equity Plan
AI Summary
OptimizeRx Corporation held its 2026 Annual Meeting of Shareholders on June 9, 2026, where several key proposals were voted upon. Shareholders approved an amendment to increase the number of shares available for awards under the 2021 Equity Incentive Plan by 1,000,000 shares, bringing the total to 5,450,000. However, a separate amendment to adopt an evergreen provision for automatic annual increases in the Equity Plan was not approved. Additionally, shareholders elected seven directors, approved executive compensation on an advisory basis, and ratified Grant Thornton, LLP as the independent auditor for 2026.
Key Highlights
- Shareholders approved a 1,000,000 share increase for the 2021 Equity Incentive Plan, raising the total to 5,450,000 shares.
- An amendment to adopt an evergreen provision for automatic annual share increases in the Equity Plan was not approved (7,001,699 votes against).
- The compensation of named executive officers was approved on an advisory basis with 11,660,549 votes in favor.
- Seven directors were elected to serve until the next annual meeting.
- Grant Thornton, LLP was ratified as the independent registered public accounting firm for fiscal year 2026 with 15,750,329 votes in favor.
- On the record date of April 10, 2026, there were 18,765,075 shares of Common Stock outstanding and entitled to vote.
Price Impact
More from OPRX